Research Article
Bioactivity Assessment of Poly(ɛ-caprolactone)/Hydroxyapatite Electrospun Fibers for Bone Tissue Engineering Application
Figure 1
SEM micrographs of fibers at different compositions: (a) 7.5% (w/v) PCL; (b) 12.5% (w/v) PCL; (c) 7.5% (w/v) PCL with 10% (w/w) nHA; (d) 7.5% (w/v) PCL with 20% nHA; (e) 12.5% (w/v) PCL with 10% (w/w) nHA; (f) 12.5% (w/v) PCL with 10% (w/w).
